MIS METALI VA AZOT, FOSFOR, KALIY BILAN MODIFIKATSIYALANGAN FTALOSIYANIN PIGMENTINING IQ SPEKTRINI TADQIQ QILISH

Qayumjonov O. . & Yusupov M. .


Annotatsiya

Ushbu maqolada azot, fosfor, kaliy va mis metali bilan modifikatsiyalangan ftalosiyanin pigmentining infraqizil (IQ) spektr tahlili o‘rganildi. Sintez qilingan pigment tarkibidagi funksional guruhlar va kimyoviy bog‘lanishlarni aniqlash maqsadida IQ-spektroskopiya usulidan foydalanildi. Tadqiqot natijalariga ko‘ra, ftalosiyanin halqasiga xos bo‘lgan C=N, C–N hamda aromatik C=C bog‘lanishlarining tebranish chastotalari kuzatildi. Shuningdek, pigment tarkibiga kiritilgan azot, fosfor va kaliy elementlari bilan bog‘liq funksional guruhlarning spektral o‘zgarishlari aniqlandi. Mis metali bilan kompleks hosil bo‘lishi natijasida spektrdagi ayrim yutilish sohalarining siljishi kuzatilib, bu metall-ftalosiyanin kompleksining muvaffaqiyatli hosil bo‘lganligini tasdiqladi. Olingan natijalar modifikatsiyalangan ftalosiyanin pigmentining tuzilishi va fizik-kimyoviy xossalarini baholashda muhim ilmiy asos bo‘lib xizmat qiladi.


Adabiyotlar

  1. Centers for Disease Control and Prevention. Antimicrobial Resistance. https://www.cdc.gov/drugresistance/index.html.
  2. Alghamdi, B. A.; Al-Johani, I.; Al-Shamrani, J. M.; Alshamrani, H. M.; Al-Otaibi, B. G.; Almazmomi, K.; Yusof, N. Y. Antimicrobial resistance in methicillin-resistant staphylococcus aureus. Saudi J. Biol. Sci. 2023, 30 (4), 103604. DOI: 10.1016/j.sjbs.2023.103604
  3. Ventola, C. L. The Antibiotic Resistance Crisis. Pharmacy and Therapeutics 2015, 40 (4), 277-283.
  4. Correia, J. H.; Rodrigues, J. A.; Pimenta, S.; Dong, T.; Zhaochu, Y. Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions. Pharmaceutics 2021, 13 (9), 1332. DOI: 10.3390/pharmaceutics13091332.
  5. Diaz-Diestra, D.; Gholipour, H. M.; Bazian, M.; Thapa, B.; Beltran-Huarac, J. Photodynamic Therapeutic Effect of Nanostructured Metal Sulfide Photosensitizers on Cancer Treatment. Nanoscale Res. Lett. 2022, 17 (33), 1-24. DOI: 10.1186/s11671-022 03674-8.
  6. Tim, M. Strategies to optimize photosensitizers for photodynamic inactivation of bacteria. J. Photochem. Photobiol., B 2015, 150, 2-10. DOI: 10.1016/j.jphotobiol.2015.05.010.
  7. Benov, L. Photodynamic Therapy: Current Status and Future Directions. Med. Princ. Pract. 2014, 24, 14-28. DOI: 10.1159/000362416.
  8. Castano, A. P.; Demidova, T. N.; Hamblin, M. R. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1 (4), 279-293. DOI: 10.1016/S1572-1000(05)00007-4.
  9. Huang, L.; Xuan, Y.; Koide, Y.; Zhiyentayev, T.; Tanaka, M.; Hamblin, M. R. Type I and Type II mechanisms of antimicrobial photodynamic therapy: An in vitro study on Gram-negative and Gram-positive bacteria. Lasers Surg. Med. 2012, 44 (6), 490-499. DOI: 10.1002/lsm.22045.
  10. Hormazábal, D. B.; Reyes, A. B.; Castro, F.; Cabrera, A. R.; Dreyse, P.; Melo-González, F.; Bueno, S. M.; González, I. A.; Palavecino, C. E. Synergistic effect of Ru(II)-based type II photodynamic therapy with cefotaxime on clinical isolates of ESBL-producing Klebsiella pneumoniae. Biomed. Pharmacother. 2023, 164, 114949. DOI: 10.1016/j.biopha.2023.114949
  11. Yu, H.; Chen, B.; Huang, H.; He, Z.; Sun, J.; Wang, G.; Gu, X.; Tang, B. Z. AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy. Biosensors 2022, 12 (5), 348. DOI: 10.3390/bios12050348.
  12. Abrahamse, H.; Hamblin, M. R. New photosensitizers for photodynamic therapy. Biochem. J. 2016, 473 (3), 347-364. DOI: 10.1042/BJ20150942.
  13. Odiljon, K., Muzafar, Y., & Doniyor, S. (2024). Synthesis and infrared spectroscopy (ir) studies of phthalocyanine pigment. containing copper, calcium, nitrogen and npk. Universum: технические науки, 10(12 (129)), 9-12.